n-(1-methyl-2-phenylethyl)adenosine has been researched along with 9-(2-hydroxy-3-nonyl)adenine in 1 studies
Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (9-(2-hydroxy-3-nonyl)adenine) | Trials (9-(2-hydroxy-3-nonyl)adenine) | Recent Studies (post-2010) (9-(2-hydroxy-3-nonyl)adenine) |
---|---|---|---|---|---|
134 | 0 | 4 | 428 | 1 | 33 |
Protein | Taxonomy | n-(1-methyl-2-phenylethyl)adenosine (IC50) | 9-(2-hydroxy-3-nonyl)adenine (IC50) |
---|---|---|---|
cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.8 | |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | 0.8 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.8 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Headrick, JP; Hinschen, AK; Rose'Meyer, RB | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and 9-(2-hydroxy-3-nonyl)adenine
Article | Year |
---|---|
Age-related changes in A(1)-adenosine receptor-mediated bradycardia.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Aging; Animals; Bradycardia; Enzyme Inhibitors; Male; Rats; Rats, Wistar; Receptors, Purinergic P1; Tritium | 2000 |